Goldman Small Cap Research, a stock market research firm focused on the small cap and micro cap sectors, has issued a research update on Rexahn Pharmaceuticals, Inc., , a clinical stage pharmaceutical company commercializing potential best-in-class oncology and CNS therapeutics.
Goldman Small Cap research issues research update on Rexahn Pharmaceuticals, Inc.